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Abstract
Background: There has been growing concern in the UK over recent years that a perceived mental health crisis is
affecting children and adolescents, although published epidemiological evidence is limited.
Methods: Two population-based UK primary care cohorts were delineated in the Aurum and GOLD datasets of the
Clinical Practice Research Datalink (CPRD). We included data from 9,133,246 individuals aged 1–20 who contributed
117,682,651 person-years of observation time. Sex- and age-stratified annual incidence rates were estimated for
attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) (age groups: 1–5, 6–9, 10–12,
13–16, 17–19), depression, anxiety disorders (6–9, 10–12, 13–16, 17–19), eating disorders and self-harm (10–12, 13–
16, 17–19) during 2003–2018. We fitted negative binomial regressions to estimate incidence rate ratios (IRRs) to
examine change in incidence between the first (2003) and final year (2018) year of observation and to examine sex-
specific incidence.
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Results: The results indicated that the overall incidence has increased substantially in both boys and girls in between
2003 and 2018 for anxiety disorders (IRR 3.51 95% CI 3.18–3.89), depression (2.37; 2.03–2.77), ASD (2.36; 1.72–3.26),
ADHD (2.3; 1.73–3.25), and self-harm (2.25; 1.82–2.79). The incidence for eating disorders also increased (IRR 1.3 95% CI
1.06–1.61), but less sharply. The incidence of anxiety disorders, depression, self-harm and eating disorders was in
absolute terms higher in girls, whereas the opposite was true for the incidence of ADHD and ASD, which were higher
among boys. The largest relative increases in incidence were observed for neurodevelopmental disorders, particularly
among girls diagnosed with ADHD or ASD. However, in absolute terms, the incidence was much higher for depression
and anxiety disorders.
Conclusion: The number of young people seeking help for psychological distress appears to have increased in recent
years. Changes to diagnostic criteria, reduced stigma, and increased awareness may partly explain our results, but we
cannot rule out true increases in incidence occurring in the population. Whatever the explanation, the marked rise in
demand for healthcare services means that it may be more challenging for affected young people to promptly access
the care and support that they need.
Introduction
Mental illness constitutes one of the leading causes of dis-
ability in the United Kingdom (UK) [1]. They are associ-
ated with several adverse trajectories, including
unemployment, low income, homelessness, criminality,
being assaulted or bullied, self-harm, suicide and other
causes of premature death [2]. It is known that psychiatric
disorder in adulthood often begins in childhood and ado-
lescence [3]; it has been estimated that three-quarters of
individuals who experience mental illness during adult-
hood will have met diagnostic criteria for a psychiatric dis-
order before reaching their 18th birthdays [4]. Thus, early
intervention, prevention and treatment are important to
enhance long-term outcomes. In the UK, there has been a
shift in the public discourse relating to mental illness, with
psychological health and wellbeing during childhood and
adolescence now at the forefront of the public health
agenda. In 2016 the Mental Health Taskforce of NHS
England published the report ‘The Five Year Forward
View for Mental Health’, which emphasised children and
young people as being a “priority group for mental health
promotion and prevention” [5] The UK Department of
Health has also provided an additional £1.4 billion for
Child and Adolescent Mental Health Services (CAMHS)
between 2015 and 2020 [6] .
Studies conducted in high-income countries indicate
marked increases in numbers of children and adolescents
diagnosed with neurodevelopmental disorders and mental
illnesses during recent decades [7]. Despite growing public
concern that more children and adolescents in the UK
may be affected by these conditions, there are no compre-
hensive and up-to-date published data on annual trends in
the incidence rates in this demographic group. The most
recent evidence reporting on the incidence of attention
deficit/hyperactivity disorder (ADHD) [8] and depression
[9, 10] indicate a stable trend or slight increases over time
up until 2013. During the same period incidence of eating
disorders appears to have remained stable in younger ado-
lescents, but decreased in older adolescents [11]. Evidence
for temporal trends in incidence of anxiety disorders [12]
and autism spectrum disorder (ASD) [13] is even more
dated, describing trends in rates up until the year 2011.
These studies also indicate a stable trend in incidence over
time. Investigation of the incidence of self-harm, a behav-
iour that is strongly linked to poor mental health, has
demonstrated an increase among adolescents in the UK
[14, 15] in recent years.
In addition to being somewhat dated, individual studies
have drawn data from different populations and settings
and have varying cohort inclusion criteria. They also differ
in terms of diagnostic classification and follow-up dur-
ation and period, hindering inter-study comparison. To
tackle these between-condition comparability issues and
to address the gap in the evidence base, we conducted a
comprehensive population-based investigation that exam-
ined temporal trends in the incidence of neurodevelop-
mental disorders, mental illnesses, and self-harm among
young people in a single study cohort for the first time.
This enabled us to assess age- and gender-specific tem-
poral trends in incidence for multiple conditions with a
uniquely high degree of comparability, as well as make use
of the accurate routine primary and secondary care link-




We delineated two cohorts utilising data from two data-
sets in the Clinical Practice Research Datalink (CPRD):
GOLD and Aurum [16]. Because the two datasets are
equivalent, we present in this study estimates that were
created by combining data from both datasets. Aurum is
a database of individuals registered with general prac-
tices in England. It consists of anonymised patient
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records that contain information about diagnoses, pre-
scribed medication, and referrals to secondary healthcare
services. It can also be linked to the Index of Multiple
Deprivation (IMD), which combines socioeconomic indi-
cators to create a composite ecological measure of
deprivation based on practice location [17]. Clinical data
are captured in the CPRD using Read codes [18]. The
Aurum dataset covers approximately 13% of England’s
population, containing over 7 million anonymised pa-
tient records from 731 practices, and is considered to be
broadly nationally representative in terms of sex, age,
and ethnicity [16]. We used the July 2019 release, which
contained 7,125,786 active patient records. GOLD is also
a primary care database that contains essentially equiva-
lent information to that held in Aurum. It draws data
from over 600 general practices in the UK that use an
electronic patient record system that is different from
that used by Aurum”. We used a “bridging” file to iden-
tify practices that have migrated from the GOLD dataset
to the Aurum dataset and removed those practices from
the GOLD dataset. This ensured that the study dataset
contained no duplicate patient records.
Study design
Cohort members
We applied the same inclusion criteria to both Aurum
and GOLD datasets (Supplementary materials Fig. S1
and S2). Children and adolescents aged 1–19 during the
study’s observation period, 1st January 2003 to 31st
December 2018, entered the cohorts if they had been
registered with their practice for at least 12 months be-
fore entry. Cohort members were followed up until the
earliest of: index self-harm episode or diagnosis of men-
tal illness, death, date of transfer out of practice, last
date of data collection, study end date or their 20th
birthday. We chose this age cut-off as this is when
adolescence ends according to the World Health Orga-
nization’s (WHO) definition and to facilitate comparison
with other recently published research [8, 14, 19].
Study measures
Psychiatric diagnoses and self-harm
We classified incident diagnosed cases and self-harm
episodes using lists of Read codes that were generated
by exhaustive searching of the CPRD’s medical directory
[20]. We identified the earliest recorded occurrence of a
psychiatric disorder or non-fatal self-harm episode for
each individual in the study cohort and noted the calen-
dar year in which these events occurred. Incidence esti-
mates from each dataset were then combined to create a
single set of estimates. The following diagnostic categor-
ies were examined because they are the most common
psychiatric illnesses in childhood and adolescence: anx-
iety disorders, ADHD, autism, depression, and eating
disorders [21]. We also chose to examine self-harm be-
cause of its strong association with poor mental health
and since recent evidence from the UK has shown inci-
dence increases in recent years [14]. The search terms
and the resulting code lists were then reviewed and re-
fined by three experienced clinical academics in our
team (a psychiatrist with expertise in self-harm and sui-
cide: NK; an academic GP with expertise in mental
health: CCG; and a child & adolescent psychiatrist: SG).
Because the descriptors for some Read codes can seem
ambiguous, we categorised codes as being either ‘strin-
gent’ or ‘inclusive’ according to their perceived likeli-
hood of correctly ascertaining a relevant diagnosis or
self-harm episode. This approach was taken because
recent evidence has demonstrated a decrease in the
number of recorded depression diagnoses and an in-
crease in the number of related symptoms that are re-
corded [22]. In the UK GPs are incentivised to comply
with review and coding protocols stipulated by the Qual-
ity and Outcomes Framework (QOF) if they record a
diagnosis of ‘depression’ using Read codes. There is evi-
dence that some practitioners may engage in ‘strategic
labelling’ (using a code such as ‘low mood’ that does not
trigger the need for follow up coding) to circumvent fi-
nancial penalties [23]. To account for these phenomena,
we present estimates for all mental illnesses that in-
cluded individuals with both symptom and diagnostic
Read codes. Incidence rates that include cases captured
by diagnostic codes only are presented separately in the
supplementary materials. For a full list of all Read codes
included in each diagnostic category, please see the
supplementary materials.
Deprivation
We measured deprivation through the Index of Multiple
Deprivation (IMD). The IMD provides a composite meas-
ure of deprivation based on information regarding income,
employment, crime, barriers to housing and services, and
health and living environment. Scores are provided for
small geographical areas, known as Lower-layer Super
Output Area (LSOA), which correspond to roughly 1500
individuals. IMD scores at LSOA level are then assigned
according to individual patient’s postcodes, and placed in
quintiles, with a higher score indicating higher levels of
deprivation [17].
Statistical analyses
We calculated annual incidence rates for each condition
stratified by sex and by age group (1–5, 6–9, 10–12, 13–
16 & 17–19 years). We generated these estimates by
manually counting the number of incident cases in each
stratum in each year and then dividing them by the
person-time at risk in the corresponding stratum. Fi-
nally, these stratified rates were directly standardised for
Cybulski et al. BMC Psychiatry          (2021) 21:229 Page 3 of 12
IMD quintile and age group. For the 1–5 years age group
we only estimated incidence rates for ADHD and aut-
ism, as diagnosis of the other conditions examined is ex-
ceptionally rare at this young age. For the same reason,
we did not estimate incidence rates for self-harm or eat-
ing disorders among children aged below 10 years. We
modelled the count data by fitting negative binomial
models. We examined temporal changes in the overall
annual incidence rates between the first and final year of
the study by generating incidence rate ratios (IRRs), ad-
justed for deprivation, sex, and age group. We also esti-
mated IRRs stratified by sex and age group, adjusted for
deprivation, to examine how change might vary across
different age and gender groups. We also tested for gen-
der interactions in models that were adjusted for
deprivation quintile, year and age. Finally, we modelled
the predicted annual changes to incidence after adjusting
for deprivation and sex. Statistical analyses were com-
pleted using STATA 16.
Results
Cohort members
In the Aurum dataset, we assessed 23,840,626 unique
patent records for eligibility. Of these, we included data
from 4,566,623 individuals that contributed 114,601,017
person-years of observation. We assessed 19,959,796 re-
cords for eligibility in the GOLD dataset, and included 2,
418,680 for analysis, contributing 28,867,639 person-
years to the denominator. Please see supplementary ma-
terials (Fig. S1 and S2) for a more detailed graphical il-
lustration of entry into and exit out of the study cohort.
Mental illnesses
Depression and anxiety disorders were the most com-
monly diagnosed mental illnesses followed by eating dis-
orders (Table 1 and Fig. 1). The incidence of depression
and anxiety disorders increased in all age and groups
over time for both sexes, whereas for eating disorders,
increases occurred in girls of all ages and boys aged 13–
16 (Table 1, Fig. 1 and supplementary Fig. S3). Incidence
rate ratios measuring overall change in incidence rates
between 2003 and 2018, adjusted for age, sex, and
deprivation quintile, demonstrated increases in the inci-
dence of depression (IRR 2.4; 95% 2.03, 2.77), anxiety
disorders (IRR 3.5; 95% CI 3.18, 3.89), and eating disor-
ders (IRR 1.3; 95% CI 1.06, 1.61). The highest incidence
of depression was observed in the 17–19 age group, in
both girls (343 per 10,000 person years in 2018; 95% CI
332–354) and boys (200 in 2018, 95% CI 192–208). After
adjusting for year, age, and deprivation, we observed an
effect of sex (IRR 2.13 95% CI 2.04–2.23). Rates of simi-
lar magnitude were observed for anxiety disorders in
2018 in the 17–19 age group (girls: 305; 95% CI 295–
316 boys: 148; 95% CI 141–155). As can be seen in
Table 1, the relative increase over time was higher in the
10–12 and 13–16 age groups for both depression and
anxiety disorders. Formal testing showed that the sex-
specific IRRs varied significantly according to age in all
conditions examined and in both sexes, except for anx-
iety disorders among boys; for the latter category, there
was no statistically significant evidence of heterogeneity
in change in incidence between the first and last obser-
vation years across age groups (p = 0.267) (Supplemen-
tary materials Table S2). For anxiety disorders, girls aged
10–12 and 13–16 saw particularly sharp increases over
time, with incidence rate ratios of 4.6 (95% CI 4.0–5.3),
and 4.6 (95% CI 4.1–5.1) observed, respectively. As with
depression, incidence rates were higher in girls than
boys (IRR 1.79 95% CI 1.72–1.84). The incidence of eat-
ing disorders was much lower compared to depression
and anxiety disorders. The highest incidence rate ob-
served for this diagnostic category was during 2018 at
ages 13–16 years in girls: 25 per 10,000; 95% CI 22–27.
The incidence was much higher in girls than boys: IRR
4.43 (95% CI 4.13–4.76). Please see the supplementary
materials for a complete array of annual incidence rates
presented by sex, age group, and condition, and formal
tests for effect modification by age and gender (Supple-
mentary materials Table S1, S2, and S3).
Neurodevelopmental disorders
The incidence of ASD increased over time in all age
groups (IRR 2.36 95% CI 1.72–3.26). It was most com-
monly diagnosed in the 1–5 age group (Table 2, Fig. 2 and
supplementary Fig. S4), with rates being highest in 2018
for both boys (60; 95% CI 57–64) and girls (17; 95% CI
16–19). In terms of relative increases among boys, the
IRRs tended to be comparable or slightly higher than
those seen for anxiety disorders and depression (Table 2).
For girls the relative increases were more substantial, with
IRRs of 7.5 (95% CI 5.1–11.1; 6–9 age group), 9.2 (95% CI
5.6–15.1; 10–12 age group), and 13.0 (95% CI 7.1–23.9;
13–16 age group). Overall, the incidence of ADHD in-
creased between 2003 and 2018 (IRR 2.36 95% CI 1.73–
3.25). Our stratified analyses showed that this increase oc-
curred in all age groups across both sexes, except for the
1–5-year-olds, among whom the incidence rate decreased
over time, with age group being a statistically significant
effect modifier. In 2018, the highest age-specific incidence
rates for ADHD were among 6–9-year-olds for both sexes
(boys: 50; 95% CI 47–54; girls: 13; 95% CI 12–15). For
both conditions, rates were higher in boys than in girls
(Autism: IRR 3.53, 95%CI 3.37–3.69; ADHD: 4.35 95% CI
3.98–4.75). Please see the supplementary materials for a
complete array of annual incidence rates presented by sex,
age group, and condition, and formal tests for effect modi-
fication by age and gender (Supplementary materials
Table S1, S2 and S3).
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Self-harm
Self-harm incidence rates increased across both sexes
and all age groups between 2003 and 2018 (IRR 2.25
95% CI 1.82–2.79: supplementary materials Fig. S5). As
with mental illnesses, the incidence rates were generally
highest at the end of the observation period, and the
rates of some age groups seemed to increase more
steeply after 2011 (Table 3 and Fig. 3). The rate was the
highest among girls in 2018 aged 13–16 (117; 95% CI
111–122) followed by girls aged 17–19 (87; 95% CI 81–
92). Across all age groups, incidence was considerably
higher in girls than in boys (IRR 3.39 95% CI 3.17–3.62).
The relative increase over time ranged from IRR 1.7
(95% CI 1.4–1.9) among 17–19-year-old boys to 4.2
(95% CI 3.3–5.3) among girls aged 10–12; IRRs varied
significantly according to age. Please see the supplemen-
tary materials for a complete array of annual incidence
rates presented by sex, age group, and condition, and
formal tests for effect modification by age and gender
(Supplementary materials Table S1, S2 and S3).
Table 1 Deprivation adjusted incidence rate ratios for mental illnesses between first and final year of the study’s observation period
by age group and gender
Aged 6–9 Aged 10–12 Aged 13–16 Aged 17–19
2003 2018 2003 2018 2003 2018 2003 2018
Female
Anxiety
Cases, n 153 624 209 1170 680 3626 1035 3158
Incidence rate 10 33 19 87 48 225 109 305
Incidence rate ratio 3.2 4.6 4.6 2.6
95% CI) (2.6, 3.9) (4.0, 5.3) (4.1, 5.1) (2.3, 3.0)
Depression
Cases, n 28 69 113 500 1155 3107 2274 3548
Incidence rate 1 4 10 36 81 189 245 343
Incidence rate ratio 1.9 3.6 2.1 1.3
(95% CI) (1.2, 3.0) (2.9, 4.4) (1.9, 2.5) (1.2, 1.5)
Eating disorders
Cases, n 60 96 196 416 161 204
Incidence rate 5 7 14 25 17 18
Incidence rate ratio 1.3 1.6 1.0
(95% CI) (0.9, 1.8) (1.2, 2.1) (0.8, 1.3)
Male
Anxiety
Cases, n 149 565 228 878 380 1350 560 1797
Incidence rate 9 29 18 62 23 78 48 148
Incidence rate ratio 3.2 3.5 3.4 2.8
(95% CI) (2.7, 3.8) (2.9, 4.2) (3.0, 3.9) (2.3, 3.3)
Depression
Cases, n 46 92 100 336 439 1553 961 2428
Incidence rate 3 5 8 23 26 89 83 200
Incidence rate ratio 1.7 3.0 3.4 2.4
(95% CI) (1.2, 2.4) (2.4, 3.8) (2.9, 3.8) (2.2, 2.6)
Eating disorders
Cases, n 42 42 42 73 42 37
Incidence rate 3 3 2 4 3 3
Incidence rate ratio 0.8 1.7 0.9
(95% CI) (0.5, 1.4) (1.2, 2.4) (0.6, 1.4)
Incidence rates are rounded to closest interger
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Sensitivity analyses: stringent vs. inclusive coding lists
and GOLD vs. Aurum datasets
Results generated using our ‘stringent’ coding lists re-
vealed similar temporal trends for all diagnostic categories
examined other than depression and anxiety disorders.
We observed an overall decrease over time in the inci-
dence of depression, and a much less substantial increase
over time for anxiety disorders. Please see the supplemen-
tary material (Fig. S6) for a side-by-side comparison of re-
sults generated with the “stringent” coding list.
Discussion
In the absence of comprehensive up-to-date population-
based epidemiological evidence, we examined temporal
trends in the annual incidence of neurodevelopmental
disorders, mental illnesses and self-harm in young
people. Between 2003 and 2018 incidence rates for
ADHD, anxiety disorders, autism, depression, and self-
harm increased in both sexes. In some age groups the
incidence more than doubled, with increases being par-
ticularly pronounced during the later years of the study’s
observation period.
The temporal increases in incidence rates that we re-
port for depression are, in terms of their magnitude,
consistent with those reported from previous studies
conducted in the UK [22] and in Norway [24]. In both
sexes, incidence was higher at ages 13–16 and 17–19,
but younger age groups saw larger relative increases.
The increases in incidence of anxiety disorders followed
a similar pattern, with the highest incidence recorded in
the two oldest age groups, mirroring results reported
from studies conducted in Wales [12] and Sweden [25].
The increases in incidence for depression and anxiety
disorders that we observed were primarily accounted for
by a growth in the number of individuals with recorded
symptoms, rather than diagnostic codes, which too is
consistent with evidence from the UK up until 2015
[22]. Studies examining prescription rates of antidepres-
sants also show large relative increases in recent years in
Sweden [26] and the UK [22]. A recently conducted
study based on CPRD GOLD investigating eating dis-
order incidence between 2004 and 2014 reported a
stable trend for girls aged 11–15 [11]. In our analysis, in-
cidence rates nearly doubled in girls aged 13–16, with
more modest increases in the 10–12 and 17–19 age
Fig. 1 Temporal trends in annual incidence rates for mental illnesses by age group, 2003–2018
Cybulski et al. BMC Psychiatry          (2021) 21:229 Page 6 of 12
groups. The increases in self-harm were of a similar
magnitude to those observed for affective disorders.
Girls aged 13–16 had the highest incidence, but rates in-
creased at a faster rate in in the 10–12 group. Evidence
from England & Wales report increases of a similar
magnitude among adolescent girls aged 13–16 [14] and
10–14 [15] only, whereas we observed increases in both
sexes and all age groups.
There is evidence for increases in prevalence of known
risk factors for mental illnesses and self-harm. For ex-
ample, recent data have demonstrated an increase in
prevalence of maternal depression in the UK [27], a
well-established risk factor for anxiety disorder and de-
pression among children and adolescents. Individuals
who live in more socially deprived areas are more likely
to have mental illnesses; deprivation levels in England
have since 2004 increased in households with adoles-
cents and young adults [28]. There is also a mounting
body of evidence for a dose-response relationship be-
tween social media usage and poor mental health out-
comes in young people [21, 29]. Greater social media
use has been linked to online harassment, sleep deficits,
low self-esteem and poor body image, which are associ-
ated with an increased risk for developing depression,
anxiety disorders and eating disorders [29]. Recent evi-
dence indicates that suicide among 15–19-year-olds in
England and Wales has increased between 2009 and
2017 [30]. Whilst increased exposure to risk factors may
explain some of the increases that we report for mental
illnesses and self-harm, it is likely that we have largely
uncovered previously unidentified need.
Compared to the other conditions examined, we ob-
served a greater variety in the magnitude of temporal
change in incidence of autism between boys and girls
and specific age groups. The relative increase was par-
ticularly pronounced in females, with IRRs of 8.2, 10.2,
and 20.5 in girls aged 6–9, 10–12, and 13–16, respect-
ively. It is important to note that incidence rates among
these groups were very low at the beginning of the study
period. Thus, while the increases in relative terms are
substantial, they are small in absolute terms. Autism in-
cidence was highest among 1–5-year-old boys, which is
Table 2 Deprivation adjusted incidence rate ratios for neurodevelopmental disorders between first and final year of the study’s
observation period by age group
Aged 1–5 Aged 6–9 Aged 10–12 Aged 13–16 Aged 17–19
2003 2018 2003 2018 2003 2018 2003 2018 2003 2018
Female
ADHD
Cases, n 28 24 80 252 32 117 20 106 a 34
Incidence rate 2 1 5 13 3 9 1 6 0 3
Incidence rate ratio 0.7 2.5 3.0 4.6 14.3
(95% CI) (0.4, 1.3) (1.9, 3.2) (2.0, 4.2) (2.8, 7.4) (3.4, 59.7)
Autism
Cases, n 90 372 31 302 17 192 12 187 8 43
Incidence rate 5 17 2 16 2 14 1 11 1 4
Incidence rate ratio 3.5 7.5 9.2 13.0 4.6
(95% CI) (2.8, 4.5) (5.1, 11.1) (5.6, 15.1) (7.1, 23.9) (2.2, 9.8)
Male
ADHD
Cases, n 153 110 454 987 233 431 129 351 20 76
Incidence rate 8 5 27 50 18 31 8 20 2 6
Incidence rate ratio 0.6 1.9 1.7 2.6 3.5
(95% CI) (0.5, 0.8) (1.6, 2.2) (1.4, 2.0) (2.1, 3.3) (2.1, 5.7)
Autism
Cases, n 379 1334 221 964 99 448 60 315 20 85
Incidence rate 20 60 13 50 8 33 4 18 2 7
Incidence rate ratio 3.2 3.8 4.5 5.1 4.0
(95% CI) (2.7, 3.8) (3.2, 4.4) (3.3, 5.3) (3.7, 7.1) (2.5, 6.5)
Incidence rates are per 10,000 person years and were directly standardised for Index of Multiple Deprivation (IMD) quintile. Incidence rates are rounded to
closest interger.
a The CPRD stipulates that cell counts below 5 are masked to protect confidentiality
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slightly lower than previously reported in the UK [31].
In terms of temporal change, studies from Sweden [32,
33] and Denmark [32] have reported prevalence in-
creases in diagnosis that are of a comparable magnitude
to the temporal trends that we observed. ADHD inci-
dence increased in all age groups, except for among 1–
5-year-olds, among whom rates decreased slightly over
time in both sexes. Across most age groups studied, our
findings were similar to those reported from a recent
UK study showing stable incidence rates between 2003
and 2011, with an upwards trend in 2011–2013. Our re-
sults may be a continuation of this trend. Studies from
the past decade show that the number of diagnoses and
prescriptions of methylphenidate have increased by simi-
lar magnitudes in Denmark [32, 34], Sweden [32, 35]
and the UK [36]. Increases in parental age, in-utero ex-
posure to antidepressants, or extremely low birth weight
have been proposed as explanations for the increased in-
cidence of ADHD and autism [7], although raised preva-
lence of rare risk factors, or of those that are not
strongly associated with the outcome, is unlikely to ac-
count for the large increases in incidence that we and
other studies have observed. Moreover, both ADHD and
autism have a strong genetic component, with an esti-
mated heritability of 70–80% [37, 38]. For these reasons,
there is a growing consensus that increases in the inci-
dence of neurodevelopmental illnesses observed over the
last 20 years are mostly due to factors independent of
aetiology, such as increased levels of awareness, detec-
tion, diagnosis and availability of services [7].
Considerable caution is needed in making inferences
regarding causal mechanisms from temporal trends in
incidence rates at population level because these
Fig. 2 Temporal trends in annual incidence rates for neurodevelopmental disorders by age group, 2003–2018
Table 3 Deprivation adjusted incidence rate ratios for self-harm
between first and final year of study’s observation period by age
group and by gender
Aged 10–12 Aged 13–16 Aged 17–19
2003 2018 2003 2018 2003 2018
Female
Cases, n 81 413 817 1934 475 952
Incidence rate 7 30 58 117 50 87
Incidence rate ratio 4.2 1.9 1.8
(95% CI) (3.3, 5.3) (1.7, 2.2) (1.6, 2.0)
Male
Cases, n 48 133 193 569 276 496
Incidence rate 4 9 11 33 24 39
Incidence rate ratio 2.5 2.9 1.7
(95% CI) (1.8, 3.6) (2.4, 3.4) (1.4, 1.9)
Incidence rates are per 10,000 person years and were directly standardised for
Index of Multiple Deprivation (IMD) quintile. Incidence rates are rounded to
closest interger
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estimates to an unknown extent are influenced by fac-
tors that are independent of underlying disease aetiology.
For example, increases over time likely reflect changes
to ascertainment, service provision and treatment.
Changes to diagnostic criteria may influence rates of
diagnosis. However, clinicians in the UK primarily rely
on the International Classification of Disease (ICD) sys-
tem for diagnosis, which during the duration of our
study has remained unchanged. Reductions to stigma as-
sociated with mental illnesses and increased awareness
among teachers and parents may also contribute to in-
creased help seeking. Estimates from studies that are less
likely to be influenced by these factors report more
modest increases in incidence over time. For example,
results from the UK Child Adolescent Mental Health
Survey conducted in 1999, 2004 and 2017, in which sev-
eral thousand randomly sampled children and adoles-
cents were assessed for mental illnesses and exposure to
their risk factors, reported increases in the prevalence of
mental illnesses among individuals aged 5–15 ranging
from 9.7 to 11.2%. Moreover, whilst the proportion of
self−/parent-reported mental illnesses has increased in
the UK, the degree of reported psychological distress has
remained stable [39].
A potential limitation of our study is that we could
not determine the validity or relative severity of diag-
nosed conditions and self-harm episodes. However, as
several studies have demonstrated, there is a significant
risk of under-ascertainment by adopting a case definition
that is unduly stringent [9, 22]. We invite interested
readers to consider the supplementary files for a side-by-
side comparison of results generated using case defini-
tions of varying levels of sensitivity (Fig. S4). Moreover,
because the CPRD does not comprehensively capture
detailed contextual information pertaining to neurodeve-
lopmental disorders, mental illnesses and self-harm, we
are unable to determine if the increases in incidence re-
flect true changes to underlying levels of psychological
distress and psychopathology in the population. Whilst
we implemented a 12-month clearance period to reduce
the risk of including prevalent cases, it is possible that
some prevalent cases were included as the CPRD does
not have complete coverage across the entire study
period. Our results reflect the incidence of recorded
diagnoses of mental illnesses in primary care; cases re-
corded in other healthcare settings may therefore be
missing. Finally, this study used data prior to the
COVID-19 pandemic and resulting restrictions and
change in service delivery.
Conclusions
In this study, we show that the number of recorded
mental illness and self-harm-related primary care epi-
sodes have increased substantially among children and
adolescents in the UK in recent years. These findings are
consistent with evidence of increased demand for spe-
cialist mental health services [40] and raise several im-
portant questions for researchers, commissioners, and
policymakers. Secular trends of mental illness-related
presentations in healthcare settings are influenced by a
complex interaction of countervailing forces, many of
which are independent of disease aetiology. Future re-
search is needed to determine if increased demand for
treatment reflects a real deterioration in psychological
wellbeing in the population and, if so, to identify the
underlying causes as this may lead to more targeted in-
terventions. This could partly be accomplished by more
frequent updates to the UK Child Adolescent Mental
Health Survey, which provides prevalence estimates of
psychiatric illnesses and their risk factors that to a lesser
extent are influenced by factors unrelated to underlying
morbidity. Identifying the most effective responses to
the reported increase in demand represents a major
challenge for policymakers and researchers alike. Whilst
increasing access to treatment is a clear priority, it is evi-
dent that many of the solutions for reducing the burden
of mental illnesses lie beyond child and adolescent men-
tal health services, and preventive efforts will need to
Fig. 3 Temporal trends in annual incidence rates for self-harm by age group, 2003–2018
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address underlying determinants, such as poverty, bully-
ing, educational stressors, and parental mental illness.
Because most psychiatric illnesses begin before adult-
hood, there is consensus among clinicians that preventa-
tive efforts targeting young people can lead to greater
personal, social and economic benefit than interventions
delivered at later stages of life [41]. The ongoing public
health response in the UK, which stresses the need for
parental support and outlines plans for increased collab-
oration between schools and mental health services [6],
is consistent with this view. However, evidence from
meta-analyses of school-based interventions is mixed
[42, 43], and more high quality evidence is needed to
better understand which interventions are effective for
whom and in what settings, and which factors are asso-
ciated with their successful implementation.
Added value of this study
Using the UK Clinical Practice Research Link (CPRD)
Aurum and GOLD datasets, we delineated a cohort
study based on routinely collected primary care patient
electronic health records. We combined the study co-
horts and investigated temporal trends in the incidence
of anxiety disorders, autism, attention-deficit hyperactiv-
ity disorder (ADHD), depression, eating disorders, and
non-fatal self-harm in children and adolescents aged 1–
19 years during 2003–2018. By presenting temporal
trends in incidence rates of self-harm and several neuro-
developmental disorder and mental illness diagnostic
categories in the same study cohort, we have addressed
some of the key limitations that are inherent with inter-
study comparisons, providing an up-to-date overview
that hitherto has been lacking from the evidence base.
Results indicate that an increasing number of children
and adolescents are seeking help for neurodevelopmen-
tal disorders, mental illnesses and self-harm behaviour.
For several age groups and diagnostic categories the in-
cidence rose by two-fold or more, with especially steep
increases occurring toward the end of the study’s obser-
vation period.
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